Adaptive Biotechnologies' Chief Operating Officer Sold Over 19,000 Company Shares. Here's What That Means for Investors.

COO Julie Rubinstein sold 19,037 shares on April 27, 2026 for about $271,000 at a weighted average price of roughly $14.23 per share. The article is a routine insider transaction update and does not provide operational or financial performance news. Market impact is likely limited unless paired with additional selling or other governance signals.

Analysis

COO Julie Rubinstein sold 19,037 shares on April 27, 2026 for about $271,000 at a weighted average price of roughly $14.23 per share. The article is a routine insider transaction update and does not provide operational or financial performance news. Market impact is likely limited unless paired with additional selling or other governance signals.